NDC 59368-298 - injoy heartburn relief
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59368-298
- Package NDCs from labels
- 59368-298-01
- Manufacturer
- Sixarp, LLC
- Effective date
- 2025-09-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| injoy heartburn relief - Sixarp, LLC | Sixarp, LLC | 2025-09-18 | HUMAN OTC DRUG LABEL |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Famotidine | FAMOTIDINE | ANI Pharmaceuticals, Inc. | 8e41e259-b161-4f11-a6f7-14e6b60885b8 | 2023-10-02 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | NorthStar Rx LLC | 04aaf296-f136-29d7-e063-6294a90affe1 | 2023-09-07 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| ANUBISMED | HA HYALURONIC | ANUBIS COSMETICS SL | eac771e2-4c1b-3808-e053-2995a90ac5fc | 2023-09-05 | Warnings | 230OU9XXE4 |
| Lipotox | SQUALENE, CHOLESTERINUM, ESTRADIOL, PROGESTERONE, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM, ARSENICUM ALBUM, LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, PETROLEUM JELLY, PHENYL BUTAZONE, PLUMBUM METALLICUM, | BioActive Nutritional, Inc. | a1538692-ca00-4e52-9b7e-409767ee27e1 | 2023-09-05 | Warnings | Z0H242BBR1 |
| Anubis Barcelona | GLYCERIN, SORBITOL, ALOE BARBADENSIS LEAF JUICE | ANUBIS COSMETICS SL | eb651769-4d98-2b3b-e053-2a95a90a36b0 | 2023-09-01 | Warnings | H3R47K3TBD |
| Anubis Barcelona | DMAE, ZIRHAFIRM | ANUBIS COSMETICS SL | f2274f8c-08aa-eb02-e053-2a95a90a3998 | 2023-09-01 | Warnings | 230OU9XXE4 |
| Anubis Barcelona Spa Line | ORYZA SATIVA (RICE) STARCH, PERLITE, PALMITIC ACID | ANUBIS COSMETICS SL | eb01a962-ab38-18ec-e053-2995a90acdeb | 2023-09-01 | Warnings | 230OU9XXE4 |
| Anubis Barcelona Total Hydrating | BETAINE, GLYCERIN, POLYSORBATE 20 | ANUBIS COSMETICS SL | eaefe3b9-9064-18b1-e053-2a95a90a5765 | 2023-09-01 | Warnings | H3R47K3TBD |
| Anubis Barcelona New Even | LACTIC ACID, CITRIC ACID, GLYCOLIC ACID | ANUBIS COSMETICS SL | eaeeb6e0-5322-20c4-e053-2995a90a9fd9 | 2023-09-01 | Warnings | H3R47K3TBD |
| FAMOTIDINE | FAMOTIDINE | Ascend Laboratories, LLC | ea50552f-f9b9-467f-a925-62ff027df607 | 2023-08-25 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| FAMOTIDINE | FAMOTIDINE | Camber Pharmaceuticals, Inc. | 8e7f9c85-d165-47c7-8950-b22adcd6cece | 2023-08-23 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | A-S Medication Solutions | 74ff64f2-d882-411f-bac8-29dfa4cb4f10 | 2023-08-09 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Maximum Strength Acid Controller | FAMOTIDINE | BETTER LIVING BRANDS LLC. | f2c031b4-de86-3a8e-e053-2a95a90a21e0 | 2023-07-30 | Warnings | 5QZO15J2Z8 |
| Equate Homeopathic Earache Drops | BELLADONNA LEAF,CALCIUM CARBONATE,CHAMOMILE,LYCOPODIUM CLAVATUM SPORE,ANEMONE PATENS WHOLE,SULFUR | Walmart Inc. | ffbe8b3e-3694-e9be-e053-6394a90a9455 | 2023-07-05 | Warnings | H0G9379FGK |
| FAMOTIDINE | FAMOTIDINE | Biocon Pharma Inc. | ea7287a4-75e0-39d2-5b2e-b72b7cb386b9 | 2023-05-21 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Medical Purchasing Solutions, LLC | bbeffa0a-2bc7-fea4-e053-2a95a90ac511 | 2023-05-08 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Medical Purchasing Solutions, LLC | b6214fc9-a274-ef45-e053-2a95a90ae43a | 2023-05-04 | Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | BluePoint Laboratories | befd8d44-c6f7-eca2-e053-2995a90a714b | 2023-03-23 | Warnings | 5QZO15J2Z8 |
| IBUPROFEN AND FAMOTIDINE | IBUPROFEN AND FAMOTIDINE | Ascent Pharmaceuticals, Inc. | 03733e49-7db4-4d98-b363-d0d23686ec72 | 2023-03-15 | Boxed warning, Warnings, Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Proficient Rx LP | fe21daca-ac48-4b46-9cb3-9a69af0c6a84 | 2023-03-01 | Warnings, Adverse reactions | 5QZO15J2Z8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.